Business Context and Reporting Period
This Form 6-K filing by GSK plc (GSK) reports a transaction in the company's own shares. The filing covers the month of September 2025, specifically detailing a share repurchase executed on September 12, 2025. The company is a Foreign Private Issuer filing under Rule 13a-16 of the Securities Exchange Act of 1934.
Key Financial Metrics and Transaction Details
The filing details a specific buyback transaction rather than providing comprehensive financial statements (revenue, profit, cash flow). Key metrics for the reported transaction are as follows:
- Date of Purchase: September 12, 2025
- Shares Purchased: 203,447 ordinary shares
- Price Range: Lowest 1,502.50p; Highest 1,531.00p
- Volume-Weighted Average Price (VWAP): 1,512.69p
- Trading Venue: London Stock Exchange (XLON)
- Broker: Merrill Lynch International
Since the commencement of the current buyback programme on June 4, 2025, the Company has purchased a total of 28,641,009 ordinary shares. Following this transaction, GSK holds 246,775,392 ordinary shares in treasury. The total number of ordinary shares in issue (excluding treasury shares) is 4,068,627,576.
Material Changes and Capital Structure
The primary material change reported is the reduction of shares in issue and the increase in treasury shares. The percentage of voting rights attributable to ordinary shares held in treasury is now 6.07%. The filing confirms that the purchased shares will be held as Treasury shares and do not carry voting rights.
Guidance, Outlook, and Risks
The filing contains no new financial guidance, revenue outlook, or management commentary regarding operational performance. It includes a standard cautionary statement regarding forward-looking statements, noting that actual results may differ materially from projections due to risks described in GSK's Annual Report on Form 20-F for 2024 and Q2 Results for 2025. The transaction was effected pursuant to a non-discretionary agreement entered into on June 4, 2025.
Key Facts for Investor Verification
- Verify the total number of shares in issue (4,068,627,576) for accurate calculation of ownership percentages under Disclosure Guidance and Transparency Rules.
- Confirm the cumulative buyback volume since June 4, 2025, stands at 28,641,009 shares.
- Note that treasury shares represent 6.07% of voting rights and are excluded from the denominator for shareholder notification thresholds.
- Review the specific transaction prices (1,502.50p to 1,531.00p) to assess the cost basis of the repurchase relative to market conditions on September 12, 2025.